| Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction S Torii, C Ono, R Suzuki, Y Morioka, I Anzai, Y Fauzyah, Y Maeda, ... Cell reports 35 (3), 2021 | 118 | 2021 |
| Conformational disorder of the most immature Cu, Zn-superoxide dismutase leading to amyotrophic lateral sclerosis Y Furukawa, I Anzai, S Akiyama, M Imai, FJC Cruz, T Saio, K Nagasawa, ... Journal of Biological Chemistry 291 (8), 4144-4155, 2016 | 49 | 2016 |
| A misfolded dimer of Cu/Zn‐superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis I Anzai, E Tokuda, A Mukaiyama, S Akiyama, F Endo, K Yamanaka, ... Protein Science 26 (3), 484-496, 2017 | 37 | 2017 |
| A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron R Maeda, J Fujita, Y Konishi, Y Kazuma, H Yamazaki, I Anzai, ... Communications Biology 5 (1), 669, 2022 | 29 | 2022 |
| Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis E Tokuda, I Anzai, T Nomura, K Toichi, M Watanabe, S Ohara, ... Molecular Neurodegeneration 12, 1-18, 2017 | 24 | 2017 |
| Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis I Anzai, K Toichi, E Tokuda, A Mukaiyama, S Akiyama, Y Furukawa Frontiers in Molecular Biosciences 3, 40, 2016 | 24 | 2016 |
| A primary role for disulfide formation in the productive folding of prokaryotic Cu, Zn-superoxide dismutase Y Sakurai, I Anzai, Y Furukawa Journal of Biological Chemistry 289 (29), 20139-20149, 2014 | 21 | 2014 |
| Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation I Anzai, E Tokuda, S Handa, H Misawa, S Akiyama, Y Furukawa Free Radical Biology and Medicine 147, 187-199, 2020 | 18 | 2020 |
| Epoxidized graphene grid for highly efficient high-resolution cryoEM structural analysis J Fujita, F Makino, H Asahara, M Moriguchi, S Kumano, I Anzai, ... Scientific Reports 13 (1), 2279, 2023 | 13 | 2023 |
| Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins T Koike, A Sugimoto, S Kosono, S Komaba, Y Kanno, T Kitamura, I Anzai, ... RSC medicinal chemistry 12 (12), 2016-2021, 2021 | 13 | 2021 |
| Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation Y Fauzyah, C Ono, S Torii, I Anzai, R Suzuki, T Izumi, Y Morioka, Y Maeda, ... Antiviral Research 186, 104999, 2021 | 11 | 2021 |
| Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein R Otsubo, T Minamitani, K Kobiyama, J Fujita, T Ito, S Ueno, I Anzai, ... Scientific Reports 12 (1), 20120, 2022 | 7 | 2022 |
| Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses T Tamura, S Torii, K Kajiwara, I Anzai, Y Fujioka, K Noda, S Taguwa, ... PLoS pathogens 18 (6), e1010593, 2022 | 5 | 2022 |
| Epoxidized graphene grid for high-throughput high-resolution cryoEM structural analysis J Fujita, F Makino, H Asahara, M Moriguchi, S Kumano, I Anzai, ... bioRxiv, 2021.11. 17.468963, 2021 | 3 | 2021 |
| Electrolyzed hypochlorous acid water exhibits potent disinfectant activity against various viruses through irreversible protein aggregation R Dianty, J Hirano, I Anzai, Y Kanai, T Hayashi, M Morimoto, ... Frontiers in Microbiology 14, 1284274, 2023 | 2 | 2023 |
| Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant K Yamaguchi, I Anzai, R Maeda, M Moriguchi, T Watanabe, A Imura, ... The Journal of Biochemistry 173 (2), 115-127, 2023 | 2 | 2023 |
| Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain I Anzai, J Fujita, C Ono, Y Kosaka, Y Miyamoto, S Shichinohe, K Takada, ... Microbiology Spectrum 12 (4), e03655-23, 2024 | 1 | 2024 |
| Establishment and clinical application of SARS-CoV-2 catch column Y Isaka, T Yoshiya, C Ono, A Uchiyama, H Hirata, S Hamaguchi, ... Clinical and Experimental Nephrology 27 (3), 279-287, 2023 | 1 | 2023 |
| Nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants R Maeda, J Fujita, Y Konishi, Y Kazuma, H Yamazaki, I Anzai, ... bioRxiv, 2021.10. 25.465714, 2021 | 1 | 2021 |
| Regular Paper Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant K Yamaguchi, I Anzai, R Maeda, M Moriguchi, T Watanabe, A Imura, ... | | 2022 |
